Genital Neoplasms, Female  >>  Perjeta (pertuzumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Perjeta (pertuzumab) / Roche
NCT00058552: A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer

Completed
2
129
US
Pertuzumab (rhuMAb 2C4)
Genentech, Inc.
Ovarian Cancer
07/04
07/04
NCT00096993: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Completed
2
131
US
Placebo, Gemcitabine, Gemzar, Pertuzumab, rhuMAb 2C4
Genentech, Inc.
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
09/07
09/07
NCT02004093: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

Completed
2
149
Canada, Europe, RoW
pertuzumab, paclitaxel, gemcitabine, carboplatin
Hoffmann-La Roche
Ovarian Cancer
09/08
09/08

Download Options